LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY)

LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY)

Aim. To study the features of lipid-lowering therapy with rosuvastatin in high and very high cardiovascular risk patients in real outpatient practice.Material and methods. Patients ≥30 years, visited internists or cardiologists of district outpatient clinics in the period from October 2013 to July 2...

Full description

Bibliographic Details
Main Authors: N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2016-05-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
dyslipidemia
total cholesterol
real practice
rosuvastatin
Online Access:https://www.rpcardio.com/jour/article/view/1228

Internet

https://www.rpcardio.com/jour/article/view/1228

Similar Items